$6.85
0[0.00%]
At close: Apr 23
$6.85
0[0.00%]
PreMarket: 4:01PM EDT
Verrica Pharmaceuticals
(NASDAQ:VRCA)Latest News for Verrica Pharmaceuticals Stock (NASDAQ:VRCA)
Verrica Pharmaceuticals Stock (NASDAQ: VRCA)
Categories: All
Wednesday, April 10, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
Monday, February 05, 2024
Monday, January 29, 2024
Thursday, January 04, 2024
Wednesday, January 03, 2024
Wednesday, December 20, 2023
- Top 4 Health Care Stocks That May Crash This MonthAvi Kapoor - Dec 20, 2023, 8:31AM
- Insiders Buying Pfizer And 3 Other StocksAvi Kapoor - Dec 20, 2023, 6:39AM
- Verrica Pharmaceuticals 10%+ Owner Perceptive Advisors Reported Purchase Of 1,233,931 Shares @ Avg Price: Of $5.63/Share In Form 4 Filing On TuesdayCharles Gross - Dec 20, 2023, 5:19AM
Friday, December 15, 2023
- Jefferies Reiterates Buy on Verrica Pharmaceuticals, Maintains $10 Price TargetBenzinga Newsdesk - Dec 15, 2023, 1:37PM
- Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Dec 15, 2023, 12:46PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Dec 15, 2023, 12:31PM
- Why Is Skin Disease-Focused Verrica Pharmaceuticals Stock Trading Higher Today?Vandana Singh - Dec 15, 2023, 11:36AM
- Verrica Pharmaceuticals shares are trading higher after the company's development and commercialization partner, Torii Pharmaceutical Co., reported top-line results from its Phase 3 trial of TO-208.Benzinga Newsdesk - Dec 15, 2023, 10:50AM
- Verrica Pharmaceuticals Shares Resume Trade Following Circuit Breaker HaltBenzinga Newsdesk - Dec 15, 2023, 10:33AM
- Market-Moving News for December 15thBenzinga Newsdesk - Dec 15, 2023, 8:47AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Dec 15, 2023, 8:08AM
- Verrica Pharmaceuticals' Development And Commercialization Partner Torii Pharmaceutical Reveals Positive Top-line Results From Confirmatory Phase 3 Trial Of TO-208 For Treatment Of Molluscum Contagiosum In JapanBenzinga Newsdesk - Dec 15, 2023, 6:02AM
Friday, November 17, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Thursday, October 12, 2023
Thursday, August 24, 2023
Wednesday, August 23, 2023
- Verrica Pharmaceuticals Supports The Recent FDA Action Targeting Manufacturers And Retailers Engaged In The Unauthorized Sale Of Products For Treating Molluscum ContagiosumBenzinga Newsdesk - Aug 23, 2023, 7:43AM
- Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $10 Price TargetBenzinga Newsdesk - Aug 23, 2023, 4:13AM
Thursday, August 10, 2023
- Verrica Pharmaceuticals Announces Presentation Of Lesion Clearance Data From An Ongoing Phase 2 Study Of VP-315 For The Treatment Of Basal Cell Carcinoma At The American Academy Of Dermatology 2023 Innovation Academy MeetingHappy Mohamed - Aug 10, 2023, 5:22PM
- Analyst Ratings for Verrica PharmaceuticalsBenzinga Insights - Aug 10, 2023, 12:00PM
- Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $10 Price TargetBenzinga Newsdesk - Aug 10, 2023, 4:44AM
Tuesday, August 08, 2023
- Including The Net Proceeds From The Debt Placement Of $44M Verrica Received, Plus $55 Million In Cash And Cash Equivalents Is Expected To Fund Operations Into Q1 Of 2025Benzinga Newsdesk - Aug 8, 2023, 7:52AM
- Verrica Pharmaceuticals Q2 EPS $(0.21) Up From $(0.32) YoY, Sales $182.00K Down From $214.00K YoYBenzinga Newsdesk - Aug 8, 2023, 7:51AM
Thursday, July 27, 2023
Tuesday, July 25, 2023
- Verrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA ApprovalVandana Singh - Jul 25, 2023, 1:03PM
- Director of Verrica Pharmaceuticals Makes $1.00M BuyBenzinga Insights - Jul 25, 2023, 11:01AM
- Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023Benzinga Insights - Jul 25, 2023, 11:00AM
- RBC Capital Maintains Outperform on Verrica Pharmaceuticals, Raises Price Target to $14Benzinga Newsdesk - Jul 25, 2023, 7:54AM
- $1M Bet On Verrica Pharmaceuticals? Check Out These 3 Stocks Insiders Are BuyingLisa Levin - Jul 25, 2023, 7:48AM
- Needham Upgrades Verrica Pharmaceuticals to Buy, Announces $10 Price TargetBenzinga Newsdesk - Jul 25, 2023, 5:22AM